What are inflow and outflow lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Inflow and Outflow Lesions in Vascular Access

Inflow lesions are stenoses affecting arterial blood flow INTO a vascular access (arteriovenous fistula or graft), while outflow lesions are stenoses affecting venous drainage FROM the access—with outflow stenoses being far more common and clinically significant. 1

Anatomic Definitions

Inflow Lesions

  • Inflow lesions involve stenoses in the arterial system supplying the vascular access, including the feeding artery or arterial anastomosis 1
  • These lesions were historically considered uncommon (5% of all lesions), but more recent angiographic experience suggests they may account for 20-25% of all lesions identified in arteriovenous grafts (AVGs) 1
  • In hemodialysis access dysfunction, inflow stenoses occur in approximately 14% of cases 2

Outflow Lesions

  • Outflow lesions are stenoses in the venous drainage pathway, including the venous anastomosis and more central veins 1
  • Venous stenosis is the most common lesion in AVGs, with approximately 90% of thrombosed grafts associated with stenosis predominantly in the outflow, at the venous anastomosis, and more centrally 1
  • Multiple lesions are frequently present within the graft or at the anastomoses 1

Hemodynamic Consequences

Outflow Stenosis Effects

  • A hemodynamically significant outflow stenosis decreases intragraft blood flow and increases intragraft pressure 1
  • This reduced blood flow may decrease hemodialysis treatment efficiency and increase the risk for vascular access thrombosis 1
  • Hemodynamically significant stenosis is defined as ≥50% reduction in normal vessel diameter accompanied by a hemodynamic, functional, or clinical abnormality 1

Inflow Lesion Effects

  • Inflow lesions and intragraft lesions are associated with low pressure in the body of the graft and venous outflow 1
  • Arterial inflow stenosis is frequently suspected by excessively negative dialysis circuit prepump pressures 1
  • In patients with low-flow access due to inflow stenosis, access flow can improve significantly after angioplasty (from 477 ± 74 mL/min to 825 ± 199 mL/min) 2

Clinical Presentation

Common Referral Criteria

  • Decreased flow rates (most common presentation for inflow stenosis) 2
  • Steal symptoms 2
  • Insufficient access maturation 2
  • Difficulty achieving hemostasis upon needle withdrawal 1
  • Spontaneous bleeding from cannulation sites 1

Diagnostic Approach

Imaging Evaluation

  • Radiological evaluation should comprise assessment of the complete arterial inflow, not just the shunt region and outflow 2
  • Contrast-enhanced magnetic resonance angiography (CE-MRA) can effectively demonstrate complete inflow (from subclavian artery), shunt region, and complete outflow 2
  • Digital subtraction angiography (DSA) remains the gold standard for confirming stenoses identified on non-invasive imaging 2
  • Color-flow duplex scanning can identify stenoses in the bypass graft or adjacent inflow/outflow arteries 3

Treatment Implications

Intervention Criteria

  • Prophylactic treatment of anatomic stenosis (≥50% diameter reduction) without hemodynamic, functional, or clinical abnormality is NOT warranted and should not be performed 1
  • Percutaneous transluminal angioplasty (PTA) or surgical repair of hemodynamically significant stenosis in a nonthrombosed AVG can maintain functionality and delay thrombosis 1
  • Preemptive treatment of stenoses reduces thrombosis rates, with 71-85% of grafts remaining free of further intervention when PTA is performed preemptively, compared to only 33-63% after thrombectomy 1

Critical Pitfall

  • The major pitfall is treating asymptomatic anatomic stenoses without hemodynamic significance—this provides no benefit in improving function or delaying thrombosis 1
  • While prophylactic treatment reduces thrombosis events, recent studies suggest it does not extend the useful lifespan of AVGs 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Inflow stenoses in dysfunctional hemodialysis access fistulae and grafts.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.